A detailed history of Cardiff Park Advisors, LLC transactions in Cybin Inc. stock. As of the latest transaction made, Cardiff Park Advisors, LLC holds 35,000 shares of CYBN stock, worth $310,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,000
Previous 35,000 -0.0%
Holding current value
$310,100
Previous $14,000 35.71%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.29 - $0.63 $4,930 - $10,710
17,000 Added 94.44%
35,000 $18,000
Q3 2022

Nov 08, 2022

BUY
$0.48 - $1.11 $2,880 - $6,660
6,000 Added 50.0%
18,000 $9,000
Q2 2022

Aug 15, 2022

BUY
$0.41 - $0.88 $4,920 - $10,560
12,000 New
12,000 $7,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.47B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Cardiff Park Advisors, LLC Portfolio

Follow Cardiff Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardiff Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cardiff Park Advisors, LLC with notifications on news.